SEC Form 4 · accession 0001477932-19-000425
Applied BioSciences Corp. · APPB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Robert Brady
Director · 10% Owner
Period of report
Oct 1, 2018
Accepted (ET)
Feb 11, 2019 · 5:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001607549
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Oct 1, 2018 | A | 200,000 | $0.00 | A | 2,061,000 | I | See footnote |
| Common StockF2,F4 | Jan 10, 2019 | G | 100,000 | $0.00 | D | 1,961,000 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Exempt transaction under SEC Rule 16b-3.
- F2Exempt transaction under SEC Rule 16b-5.
- F31,661,000 shares held by John R. Brady Living Trust, and 400,000 shares held by Equinox Consulting LLC.
- F41,561,000 shares held by John R. Brady Living Trust, and 400,000 shares held by Equinox Consulting LLC.